bioAffinity Technologies Inc. Warrant
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. It operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell… Read more
Market Cap & Net Worth: bioAffinity Technologies Inc. Warrant (BIAFW)
bioAffinity Technologies Inc. Warrant (NASDAQ:BIAFW) has a market capitalization of $4.78K ($4.78K) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #34284 globally and #11174 in its home market, demonstrating a 124.69% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying bioAffinity Technologies Inc. Warrant's stock price $0.50 by its total outstanding shares 9656 (9.66K).
bioAffinity Technologies Inc. Warrant Market Cap History: 2022 to 2026
bioAffinity Technologies Inc. Warrant's market capitalization history from 2022 to 2026. Data shows change from $4.06K to $4.78K (-33.50% CAGR).
bioAffinity Technologies Inc. Warrant Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how bioAffinity Technologies Inc. Warrant's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
bioAffinity Technologies Inc. Warrant's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $4.06K | $4.80K | -$8.15 Million | 0.84x | N/A |
| 2023 | $830.42 | $2.53 Million | -$7.94 Million | 0.00x | N/A |
| 2024 | $3.25K | $9.36 Million | -$9.04 Million | 0.00x | N/A |
Competitor Companies of BIAFW by Market Capitalization
Companies near bioAffinity Technologies Inc. Warrant in the global market cap rankings as of March 18, 2026.
Key companies related to bioAffinity Technologies Inc. Warrant by market ranking:
- TONGDA GRP HLDGS (MU:TJC): Ranked #34275 globally with a market cap of $2.00 Million USD ( €1.95 Million EUR).
- Abpro Holdings, Inc. (NYSE:ABP): Ranked #34276 globally with a market cap of $2.00 Million USD.
- AFP Capital SA (SN:AFPCAPITAL): Ranked #34285 globally with a market cap of $1.99 Million USD ( CL$2.00 Billion CLP).
- Prevision Sanitaria Nacional Gestion SOCIMI S.A. (MC:YPSN): Ranked #34286 globally with a market cap of $1.99 Million USD ( €1.94 Million EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #34275 | TONGDA GRP HLDGS | MU:TJC | $2.00 Million | €0.01 |
| #34276 | Abpro Holdings, Inc. | NYSE:ABP | $2.00 Million | $6.75 |
| #34285 | AFP Capital SA | SN:AFPCAPITAL | $1.99 Million | CL$250.00 |
| #34286 | Prevision Sanitaria Nacional Gestion SOCIMI S.A. | MC:YPSN | $1.99 Million | €16.10 |
bioAffinity Technologies Inc. Warrant Historical Marketcap From 2022 to 2026
Between 2022 and today, bioAffinity Technologies Inc. Warrant's market cap moved from $4.06K to $ 4.78K, with a yearly change of -33.50%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $4.78K | +41.43% |
| 2025 | $3.38K | +4.04% |
| 2024 | $3.25K | +291.16% |
| 2023 | $830.42 | -79.52% |
| 2022 | $4.06K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of bioAffinity Technologies Inc. Warrant was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.78K USD |
| MoneyControl | $4.78K USD |
| MarketWatch | $4.78K USD |
| marketcap.company | $4.78K USD |
| Reuters | $4.78K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.